Wedelolactone-Loaded Micelles Ameliorate Doxorubicin-Induced Oxidative Injury in Podocytes by Improving Permeability and Bioavailability

Wedelolactone (WED) is commonly used for the treatment of doxorubicin (DOX)-induced kidney damage, but its efficacy is limited by its poor solubility and bioavailability. In this study, we developed a novel delivery system of WED-loaded micelles (WED-M) with Solutol(®) HS15 and lecithin at an optimi...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Liang, Li, Zhi-yong, Wang, Long, Li, Xing-hua, Chen, Ya-ping, Yang, Bing, Yang, Dang, Lian, Yuan-pei, Hou, Xue-feng, Li, Jun-hui, Ding, Shu-min, Jia, Xiao-bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883003/
https://www.ncbi.nlm.nih.gov/pubmed/31824933
http://dx.doi.org/10.3389/fbioe.2019.00333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883003/
https://www.ncbi.nlm.nih.gov/pubmed/31824933
http://dx.doi.org/10.3389/fbioe.2019.00333

Ejemplares similares